Cargando…

Effective use of telemedicine in Mumbai with a cohort of extensively drug-resistant “XDR” tuberculosis patients on bedaquiline during COVID-19 pandemic

Detalles Bibliográficos
Autores principales:	Udwadia, Zarir F., Sharma, Samridhi, Mullerpattan, Jai B., Gajjar, Ishita, Pinto, Lancelot
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066929/ https://www.ncbi.nlm.nih.gov/pubmed/33402651 http://dx.doi.org/10.4103/lungindia.lungindia_464_20

Ejemplares similares

Possible impact of the standardized Category IV regimen on multidrug-resistant tuberculosis patients in Mumbai
por: Udwadia, Zarir F, et al.
Publicado: (2016)

Increased Moxifloxacin Dosing Among Patients With Multidrug-Resistant Tuberculosis With Low-Level Resistance to Moxifloxacin Did Not Improve Treatment Outcomes in a Tertiary Care Center in Mumbai, India
por: Tornheim, Jeffrey A, et al.
Publicado: (2021)

Tuberculosis Management by Private Practitioners in Mumbai, India: Has Anything Changed in Two Decades?
por: Udwadia, Zarir F., et al.
Publicado: (2010)

Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis
por: Maryandyshev, Andrey, et al.
Publicado: (2017)

Cycloserine did not increase depression incidence or severity at standard dosing for multidrug-resistant tuberculosis
por: Tornheim, Jeffrey A., et al.
Publicado: (2022)

Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy
por: Codecasa, Luigi R., et al.
Publicado: (2017)

Prevalence of pre-extensively drug-resistant tuberculosis (Pre XDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) among extra pulmonary (EP) multidrug resistant tuberculosis (MDR-TB) at a tertiary care center in Mumbai in pre Bedaquiline (BDQ) era
por: Utpat, Ketaki V., et al.
Publicado: (2023)

Tropical pulmonary eosinophilia - A review
por: Mullerpattan, Jai B., et al.
Publicado: (2013)

Yield of Systematic Longitudinal Screening of Household Contacts of Pre-Extensively Drug Resistant (PreXDR) and Extensively Drug Resistant (XDR) Tuberculosis Patients in Mumbai, India
por: Paryani, Roma Haresh, et al.
Publicado: (2020)

Multidrug-resistant-tuberculosis treatment in the Indian private sector: Results from a tertiary referral private hospital in Mumbai
por: Udwadia, Zarir F., et al.
Publicado: (2014)

Private patient perceptions about a public programme; what do private Indian tuberculosis patients really feel about directly observed treatment?
por: Pinto, Lancelot M, et al.
Publicado: (2010)

India should speed up access to bedaquiline-based all-oral regimens, not procrastinate further
por: Udwadia, Zarir F, et al.
Publicado: (2021)

Improved pulmonary function following pirfenidone treatment in a patient with progressive interstitial lung disease associated with systemic sclerosis
por: Udwadia, Zarir F., et al.
Publicado: (2015)

Who will teach the teachers: An analysis of the inhaler technique of Indian patients and health care providers in a tertiary health care centre
por: Mullerpattan, Jai Bharat, et al.
Publicado: (2016)

Why “covering all” in the DOTS program is not necessarily “all being covered” by the DOTS program
por: Pinto, Lancelot Mark, et al.
Publicado: (2010)

Safety and effectiveness of all-oral and injectable-containing, bedaquiline-based long treatment regimen for pre-XDR tuberculosis in Vietnam
por: Nguyen, Thi Mai Phuong, et al.
Publicado: (2022)

Use of nintedanib in patients with idiopathic pulmonary fibrosis: Initial Indian experience
por: Mullerpattan, Jai B, et al.
Publicado: (2019)

Pharmacokinetic analysis of linezolid for multidrug resistant tuberculosis at a tertiary care centre in Mumbai, India
por: Resendiz-Galvan, Juan Eduardo, et al.
Publicado: (2023)

First experience of effectiveness and safety of bedaquiline for 18 months within an optimised regimen for XDR-TB
por: Lewis, Joseph M., et al.
Publicado: (2016)

Effectiveness and safety of bedaquiline-containing regimens for treatment on patients with refractory RR/MDR/XDR-tuberculosis: a retrospective cohort study in East China
por: Zhang, Shao-Jun, et al.
Publicado: (2022)

Bedaquiline and Linezolid for Extensively Drug-Resistant Tuberculosis in Pregnant Woman
por: Jaspard, Marie, et al.
Publicado: (2017)

Adverse effects of bedaquiline in patients with extensively drug-resistant tuberculosis
por: Gaida, Razia, et al.
Publicado: (2020)

MDR & XDR Tuberculosis
por: Kumar, Prahlad
Publicado: (2017)

XDR Tuberculosis: A Looming Threat
por: Sharma, Vishal, et al.
Publicado: (2009)

Extensively drug resistant tuberculosis (XDR-TB): A potential threat
por: Marwar, Anaga, et al.
Publicado: (2010)

Few eligible for the newly recommended short course MDR-TB regimen at a large Mumbai private clinic
por: Udwadia, Zarir F., et al.
Publicado: (2019)

Extensively Drug-Resistant Tuberculosis (XDR-TB) - A Potential Threat in Ireland
por: Mc Laughlin, Anne Marie, et al.
Publicado: (2007)

Quality of drug-resistant tuberculosis care: Gaps and solutions
por: Udwadia, Zarir, et al.
Publicado: (2019)

Disseminated tuberculosis with immune thrombocytopenic purpura
por: Dagaonkar, Rucha S., et al.
Publicado: (2012)

First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline
por: Tadolini, Marina, et al.
Publicado: (2016)

Bedaquiline, Delamanid, Linezolid, and Clofazimine for Treatment of Pre-extensively Drug-Resistant Tuberculosis
por: Padmapriyadarsini, Chandrasekaran, et al.
Publicado: (2022)

Bronchoalveolar lavage contamination by sterile containers: A unique and unrecognized cause of a false-positive galactomannan
por: Kathar, Sushil Shriram, et al.
Publicado: (2017)

A study on pre-XDR & XDR tuberculosis & their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north India
por: Singhal, Parul, et al.
Publicado: (2016)

Tuberculosis in South Asia: a tide in the affairs of men
por: Basnyat, Buddha, et al.
Publicado: (2018)

Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Children: The Role of Bedaquiline and Delamanid
por: Pecora, Francesco, et al.
Publicado: (2021)

Draft Genome Sequence of the First Isolate of Extensively Drug-Resistant (XDR) Mycobacterium tuberculosis in Malaysia
por: Ng, Kee Peng, et al.
Publicado: (2013)

Activity of Semi-Synthetic Mulinanes against MDR, Pre-XDR, and XDR Strains of Mycobacterium tuberculosis
por: Martínez-González, María Alejandrina, et al.
Publicado: (2021)

Acquired Resistance of Mycobacterium tuberculosis to Bedaquiline
por: Andries, Koen, et al.
Publicado: (2014)

Daily Dosing for Bedaquiline in Patients with Tuberculosis
por: Salinger, David H., et al.
Publicado: (2019)

Analysing non-synonymous mutations in XDR and MDR tuberculosis drugs
por: Surana, Pallavi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5pq4ni2dsekhfil8vio7bg5vs1